Overview

Microbubbles or Ultrasound Contrast Agents Market is poised to value over CAGR of over 24.8% during the forecast period 2022 to 2028.

Microbubbles are capable of reflecting ultrasound waves and they are intravenously administered and are circulated in the blood like red blood cells. These gas bubbles are applied with ultrasound pulses with a certain frequency and the bubbles change their dimensions, thereby creating a strong echo from the perfused tissue area. Therefore, using microbubble contrast reagents for ultrasound diagnosis helps in improving the backscattering or ultrasound reflection of the waves which leads to the production of an echocardiogram with contrast enhancements. The microbubbles have a fundamental disadvantage. They do not last longer in circulation and this shall affect the outcome of the echocardiogram of a complex tumor.

Market Segmentation:

By Disease Area
•   Cardiovascular Diseases
•   Renal Diseases
•   Others
By Application
•   Drug Delivery
•   Molecular Imaging
•   Stem Cell Delivery
•   Gene Therapy
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is classified into disease area, application and region. The disease area segment is fragmented into renal diseases, cardiovascular diseases and others. The cardiovascular disease segment is anticipated to account for the largest microbubbles or ultrasound contrast agents market share and this can be credited to a rise in the number of patients diagnosed with cardiovascular diseases, increased adoption of microbubbles in echocardiogram procedures for obtaining an optimum echocardiogram to effectively analyse the issue. The application segment is bifurcated into drug delivery, molecular imaging, stem cell delivery and gene therapy. The molecular imaging segment is anticipated to lead the market, and this can be attributed to an increased acceptance of microbubbles in different diagnostic procedures that are based on ultrasound technology. Furthermore, a rising necessity for monitoring the biomarker status in imaging inflammation, vascular endothelium and visualizing the vasculature of a tumor has boosted the proliferation of the market.

Regional Analysis:

The North America region is predicted to dominate the market, and this is due to the increased cancer patient population along with a rise in the adoption of ultrasound procedures integrated with microbubbles. Furthermore, a strong presence of key market players has bolstered the market growth in the region. However, the Asia Pacific region is predicted to grow at substantial rate and this growth will be mainly driven by countries like India, Japan, South Korea with a rise in the awareness programs undertaken by the government bodies for improving public health and advancements in the healthcare infrastructure developed in the region.

Competitive Landscape:

The prominent players of the market include GE Healthcare, Bristol-Myers Squibb, Daiichi Sankyo Company Limited, Lantheus Holdings Inc., Bracco, nanoPET Pharma GmbH.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global microbubbles or ultrasound contrast agents market by disease area, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com